Infliximab for the treatment of rheumatoid arthritis.
BACKGROUND: Infliximab is a human murine chimeric anti-tumour necrosis factor alpha monoclonal antibody recently approved for the treatment of refractory RA. OBJECTIVES: To assess the efficacy and safety of infliximab for the treatment of rheumatoid arthritis. SEARCH STRATEGY: Electronic databases...
Үндсэн зохиолчид: | Blumenauer, B, Judd, M, Wells, G, Burls, A, Cranney, A, Hochberg, M, Tugwell, P |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
2002
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Etanercept for the treatment of rheumatoid arthritis.
-н: Blumenauer, B, зэрэг
Хэвлэсэн: (2003) -
Etanercept for the treatment of rheumatoid arthritis
-н: Blumenauer, B, зэрэг
Хэвлэсэн: (2004) -
Etanercept for the treatment of rheumatoid arthritis.
-н: Lethaby, A, зэрэг
Хэвлэсэн: (2013) -
Infliximab in the treatment of rheumatoid arthritis
-н: A Perdriger
Хэвлэсэн: (2009-05-01) -
The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: A systematic review and economic evaluation
-н: Jobanputra, P, зэрэг
Хэвлэсэн: (2002)